<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03950206</url>
  </required_header>
  <id_info>
    <org_study_id>ICG and endometriosis</org_study_id>
    <nct_id>NCT03950206</nct_id>
  </id_info>
  <brief_title>Intraoperative Assessment of Ureteral Perfusion in Women With Endometriosis</brief_title>
  <official_title>Intraoperative Assessment of Ureteral Perfusion Using Indocyanine Green Angiography in Women Submitted to Laparoscopic Surgery for Endometriosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Deep infiltrating endometriosis (DIE) is a severe form of endometriosis in which lesions
      affect retroperitoneal tissue and pelvic organs wall. It is often characterized by pain
      (dysmenorrhea, dysuria, dyspnea, dyspareunia, and chronic pelvic pain) and infertility,
      drastically impacting on women' quality of life. It is typically multifocal, involving
      uterosacral ligaments, the upper third of posterior vaginal wall, bowel, bladder, and
      ureters.

      Indocyanine green (ICG) is an anionic tricarbocyanine molecule able to bind to plasma
      proteins into the vascular system and to become fluorescent if excited by near-infrared light
      (NIR). NIR-ICG imaging is used in gynecology for the intraoperative diagnosis of occult
      peritoneal and deep endometriosis at white light and to assess tissue perfusion and guide
      surgical strategy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with clinical and trans-vaginal / abdominal ultrasound diagnosis of deep
      endometriosis, undergoing surgery for the removal of endometriotic lesions are included in
      the study.

      Ureter perfusion will be intraoperatively assessed using indocyanine green angiography.

      After surgery, patients will be included in the post-operative follow-up, as usual in our
      clinical practice.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility and safety: Clavien-Dindo Classification (from Grade I to V)</measure>
    <time_frame>From the surgery time, assessed up to 7 days after surgery</time_frame>
    <description>Evaluation of feasibility and safety of indocyanine green angiography in women submitted to laparoscopic surgery for endometriosis, considering complications using Clavien-Dindo Classification (from Grade I to V)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ureteral vascularization</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Evaluation of ureteral vascularization using indocyanine green angiography in women submitted to laparoscopic surgery for endometriosis</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Endometriosis</condition>
  <arm_group>
    <arm_group_label>Women with endometriosis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Women undergoing laparoscopic surgery for endometriosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Indocyanine green angiography</intervention_name>
    <description>Intravenous ICG (PULSION Medical Systems SE, Feldkirchen, Germany) will be used for the intraoperative evaluation of ureteral vascularization. Twenty-five milligrams of indocyanine green will be diluted in 10 ml of soluble water, and a bolus of 0.25 mg/Kg will be injected through a peripheral vein. During laparoscopy, a NIR camera-head (KARL STORZ Gesellschaft Mit Beschr√§nkter Haftung&amp;amp; Co., Tuttlingen, Germany) will be used to visualize the ureteral vascularization.</description>
    <arm_group_label>Women with endometriosis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing laparoscopic surgery for endometriosis

          -  informed consent to participate in the study

        Exclusion Criteria:

          -  known or suspected allergy to iodide

          -  history of active pelvic infection

          -  presence of intra-abdominal or pelvic malignancy

          -  pelvic radiation therapy

          -  hyperthyroidism

          -  liver dysfunction

          -  serum creatinine &gt; 2.0 mg/dL
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Diego Raimondo</name>
      <address>
        <city>Bologna</city>
        <state>BO</state>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diego Raimondo, MD</last_name>
      <phone>0512144389</phone>
      <phone_ext>0039</phone_ext>
      <email>die.raimondo@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Renato Seracchioli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Diego Raimondo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giulia Borghese, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Manuela Mastronardi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>May 13, 2019</study_first_submitted>
  <study_first_submitted_qc>May 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2019</study_first_posted>
  <last_update_submitted>November 16, 2019</last_update_submitted>
  <last_update_submitted_qc>November 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</investigator_affiliation>
    <investigator_full_name>Renato Seracchioli</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Endometriosis</keyword>
  <keyword>Ureters</keyword>
  <keyword>Indocyanine green angiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

